These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20607537)

  • 1. Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.
    Keane C; Mollee P; Marlton P; Gill D
    Ann Hematol; 2011 Mar; 90(3):359-60. PubMed ID: 20607537
    [No Abstract]   [Full Text] [Related]  

  • 2. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
    Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
    Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
    Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
    Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
    Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy induced esophageal stricture.
    Kassam A; Mandel K
    Pediatr Blood Cancer; 2009 Apr; 52(4):551. PubMed ID: 19061235
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
    Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia.
    Kerridge I; Lowe M; Seldon M; Enno A; Deveridge S
    Arch Intern Med; 1997 Aug 11-25; 157(15):1753-7. PubMed ID: 9250237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
    Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute promyelocytic leukemia and HIV-1 infection: case report and review of the literature.
    Kudva GC; Maliekel K; Richart JM; Batanian JR; Grosso LE; Sokol-Anderson M; Petruska PJ
    Am J Hematol; 2004 Nov; 77(3):287-90. PubMed ID: 15495246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
    Zhou L; Mohsen A; Khan MA; Guthrie T
    J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute myeloid leukaemia without blood transfusion in a member of Jehovah's Witnesses].
    Larsen C; Jensen MK
    Ugeskr Laeger; 2011 Nov; 173(46):2960-2. PubMed ID: 22094219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
    Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
    Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
    Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemia.
    Fujisawa S; Naito K; Matsuoka T; Kobayashi M
    Int J Hematol; 2007 Jun; 85(5):418-20. PubMed ID: 17562618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jehovah's Witnesses with leukaemia.
    Cullis JO; Smith AG
    Lancet; 1990 Oct; 336(8722):1075-6. PubMed ID: 1977056
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Krishna R; Sorour Y; Goepel JR; Kirkbride P; Smith DJ; Ezaydi Y; Dalley CD; Snowden JA
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):769-71. PubMed ID: 18995171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.